IBEC and GENOMICA present NEDxA, first fruit of their collaboration Blog Post

Head of Technology Transfer Xavier Rubies, as well as representing IBEC as a research centre related to health, joined forces with representatives from Genomica to reveal NEDxA, a nano-electronic diagnostic array, at MEDICA, the world forum for medicine in Düsseldorf on 14th-17th November. The device –developed by the IBEC-Genomica Joint Unit located at IBEC’s headquarters at the Barcelona Science Park– carries out analysis to detect Human Papillomavirus (HPV) in a cheap, quick and convenient desktop device. 

 

Omega-3 fatty acids stimulate brown adipose tissue metabolism Blog Post

Omega-3 fatty acids are able to stimulate the activation of brown and beige adipose tissues, a discovery that would promote the development of new therapies for obesity and other metabolism diseases, according to a research study published in the journal Nature Communications under the supervision of Professor Francesc Villarroya, from the Department of Biochemistry and Molecular Biomedicine and member of the Institute of Biomedicine of the University of Barcelona (IBUB) –located at PCB– and the Biomedical Research Center Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN) of the Institute of Health Carlos III.

 

Understanding epigenetic changes: one more step towards precision medicine Blog Post

Researchers at the Centro Nacional de Análisis Genómico (CNAG-CRG), based at the Barcelona Science Park (PCB), participate in a series of articles simultaneously published by scientists from across the International Human Epigenome Consortium (IHEC) in prestigious scientific journals. The collection of publications showcases the achievements and scientific progress made by IHEC in core areas of current epigenetic investigations.

 

Avizorex receives the EntrepreneurXXI Award in the Lifes Science category Blog Post

Today, the Caixaforum auditorium in Barcelona has hosted the 10th EmprendedorXXI Awards Ceremony, an initiative promoted by “la Caixa”, through Caixa Capital Risc, and co-awarded by the Ministry of Economy, Industry and Competitiveness, through Enisa.The biotechnology company, Avizorex Pharma, an ophthalmology biotech company with offices at Barcelona Science Park (PCB), has received the award in the Life Sciences category.

 

IRB Barcelona launches a campaign entitled “Future” to increase public awareness of biomedical research Blog Post

Today the Institute for Research in Biomedicine (IRB Barcelona) has launched a fundraising campaign called “Futur” (#IRBfutur). The campaign, which will run for two months, seeks to raise public awareness of the role that biomedical researchplays in advancing medicine, and the need to train scientists to ensure they can make the discoveries that may one day save our lives. The initiative aims to raise 25,000 euros to fund the first year of a PhD student at IRB Barcelona. The campaign is part of “Giving Tuesday”, a day devoted to charitable donations, which this year falls on Tuesday 29 November.

 

Esteve and Boehringer Ingelheim enter into an agreement to help patients with atrial fibrillation Blog Post

Esteve and Boehringer Ingelheim have reached an agreement whereby they enter into a joint promotion to share their commitment to improving the lives of patients with non-valvular atrial fibrillation (NVAF) at risk of suffering a stroke. In June 2012, Esteve has moved its Center for Drug Discovery and Preclinical Development to the Barcelona Science Park (PCB) in an attempt to shorten development time and speed up the arrival to market of innovative new drugs. 

 

IRB Barcelona scientist Eduard Batlle wins the 2016 Carmen and Severo Ochoa Prize Blog Post

Coordinator of the Oncology Programme at the Institute for Research in Biomedicine (IRB Barcelona) and ICREA research professor Eduard Batlle has won the 2016 Carmen y Severo Ochoa Prize. Presented by the Fundación Carmen and Severo Ochoa since 1995, these awards recognise molecular biology research undertaken by scientists in Spain. The prize presentation ceremony will be held on Wednesday 16 November at the Residencia de Estudiantes in Madrid.

 

Drug repurposing, a new hope for rare diseases Blog Post

Under the theme Drug repurposing for rare diseases. The cure of the 21st centuryB·Debate – an initiative by Biocat and  “la Caixa” Foundation– will be holding, in association with the Barcelona Science Park (PCB) and Hospital Sant Joan de Déu (HSJD), an international expert gathering at CosmoCaixa on 17 and 18 November to help identify new therapeutic strategies for rare diseases, with a special emphasis on drug repurposing already approved for other diseases. 

 

TPM Program: twenty-five years promoting quantity, quality and efficiency in organ donations over the world Blog Post

Promoting training for the experts of the field of organ, tissue and human cell transplantation and donation is the main aim of the Transplant Procurement Management, a worldwide reference in the training of health professionals of this field, which has taught around 13.000 experts from 100 countries over the world since it was created 25 years ago. This educational program is led by Dr. Martí Manyalich director of the DTI Foundation (Donation & Transplantation Institute), based at the Barcelona Science Park.